Artificial nanomotors with advanced functions, such as motility and miniaturization, enabled the exploration of new strategies for cancer treatment. However, these nanorobots do not contain multiple functions that could help progress this technology rapidly.
In a recent study, researchers proposed a dual-source powered Janus nanomotor containing multiple photo-theranostic functions, for example, photodynamic therapy (PDT), surface-enhanced Raman scattering (SERS) sensing, photothermal therapy (PTT) and fluorescence imaging/photoacoustic imaging (PAI). This study is available as a pre-proof in Biomaterials.
Merits of Theranostics Approach in Biomedicine
The combination of diagnosis and therapy is referred to as theranostics. One of the key advantages of this strategy is that it enables image-guided therapy. Several light-sensitive bioimaging and therapeutic agents are available that allow remote controllability and non-invasiveness, with significant effectiveness.
Theranostic capacity has been immensely expanded with the development of PAI, which acts as micro/nano-carriers. Additionally, therapeutic methods, such as PDT and PTT, exhibited significant efficacy in cancer treatment. Although photo-theranostics has combined imaging and therapeutic modalities into a single platform for better clinical outcomes, formulating efficient imaging/therapy reagents has remained challenging.
Biomedically engineered micro-/nanomotors (MNMs) have been applied in microsurgery, minimally invasive treatment, and disease diagnosis. The development of synthetic MNMs-based nanoplatforms with active self-propulsion capacity at the nanoscale has enabled the precise targeting of tumor cells. Furthermore, this nanosystem is stable in the tumor microenvironment and has displayed enhanced cell and tissue penetration capacity. Therefore, the MNM-based nanoplatform has great potential in cancer photo-theranostics.
Development of Novel Nanomotors for Photo-Theranostics Application
Recently, researchers have designed a new photo-theranostic nanomotor by combining several diagnostic and therapeutic functions. They created up-converted nanoparticles (UCNPs) in multiple layered structures of NaYF4:Yb, Tm@NaYF4:Yb, and Nd@NaYF4, via thermal decomposition, whose average diameters were estimated to be approximately 29.1 nm, 42.7 nm, and 59.8 nm, respectively.
The UCNP nanocrystals were encapsulated by a mesoporous silica (mSiO2) coating layer, forming UCNPs@mSiO2 (UMS). Subsequently, the amino group was introduced onto the mSiO2 surface (UMS-NH2) and gold (Au) was sputtered to one side. Thereby, Au-functionalized Janus nanoparticles were formed, which were denoted as UCNP@mSiO2@Au (UMSA).
To equip the nanomotor with PDT, photosensitizer 5,10,15,20-tetrakis (4-aminophenyl) porphyrin (TAPP) was added to the surface of the mSiO2 forming UMSTA3. Scientists next modified TAPP with glutaraldehyde (GA). Finally, a catalase was added to UMSTA3 that served as a nano-engine to provide thrust force to the nanomotor (UMSTCA3). Because of its nanoscale dimension, UMSTCA3 nanomotors exhibited a high rotational diffusion coefficient
A specially designed software was written to measure the nanomotor trajectories. Analysis of the nanomotor trajectories showed higher H2O2 fuel concentrations promoted greater diffusiveness. Interestingly, the nanomotor’s motility could be increased by enhancing H2O2 concentration and application of NIR light.
The main functions of the UMSTCA3 nanomotor are to detect tumor cells, performing dual-modal bioimaging (PAI/FLI), and NIR-triggered phototherapy (PTT/PDT). This nanomotor uses H2O2 tumor biomarker sensing to achieve tumor cell sensing. PDT treatment is associated with producing reactive oxygen species (ROS) to eliminate tumor cells.
Taken together, the current multifunctional nanomotor is equipped with PTT, SERS, and PDT sensing functions. The combination of UCNPs and photosensitizer offers PDT, while the gold nano-shell offers SERS and PTT sensing.
Efficacy of Cancer Photo-Theranostics through in vivo and in vitro Studies
The photo-theranostic capability of the nanomotor was tested using cellular experiments and animal models. The biological safety profile of both UMSTA3 and UMSTCA3 nanomotors was analyzed. In vitro studies, using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (MTT) assays, demonstrated considerable biocompatibility and marginal cytotoxicity.
Compared to a single PTT treatment for cancer, UMSTCA3 nanomotors with synergistic phototoxicity of PTT and PDT eliminated cancer cells more efficiently. Additionally, the viability of cancer cells significantly decreased on elevating the NIR light dose. The live/dead assay also revealed that an increase in the NIR light significantly enhanced the number of dead cells.
Animal models were used to investigate the effectiveness of UMSTCA3 nanomotors in vivo. 4T1 tumor-bearing mice were injected with the newly designed nanomotors to test the effectiveness of nanomotors in cancer treatment. Tumor volumes of the treated mice were measured, and the result suggested that a single treatment of NIR laser irradiation or UMSTCA3 injection was insufficient to suppress cancer development. Maximum suppression of cancer cells was observed in mice treated with the combination of UMSTA3 and NIR laser at 808 nm.
In the future, more research is required to validate the findings. Also, the biocompatibility of the nanomotors needs to be assessed in further detail.
News
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]
Scientists Finally Uncover How a “Forever Chemical” Causes Birth Defects
PFDA, a PFAS “forever chemical,” can cause craniofacial birth defects by disrupting retinoic acid regulation during fetal development, revealing the first clear molecular mechanism behind the link. Researchers have long linked perfluoroalkyl and polyfluoroalkyl substances (PFAS), [...]
Scientists Have Discovered These Deadly Parasites Are Secretly Swapping DNA
Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread. A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than [...]
Stanford’s Revolutionary New Microscope Reveals Living Cells in Stunning Detail
Stanford researchers have developed a microscope that can show how nanostructures interact inside living cells at the highest resolution achieved so far. The view into living cells just got better. Stanford researchers have merged [...]
What Bundibugyo Ebola vaccines and treatments are under development
By Mariam Sunny and Jennifer Rigby May 29 (Reuters) – Global health authorities are racing to identify medical options to help contain an Ebola outbreak in eastern Democratic Republic of Congo, linked to the [...]
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
